A review on phytochemistry, pharmacology and toxicology studies of Aconitum

Journal of Pharmacy and Pharmacology

Volumn 67, Issue 1, 2015, Pages 1-19

  Nyirimigabo, Eric ^a,b   Xu, Yanyan ^a   Li, Yubo ^a   Wang, Yuming ^a   Agyemang, Kojo ^a,c   Zhang, Yanjun ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Rwanda Development Board   (Rwanda)

^c University of Ghana   (Ghana)

Author keywords

aconite poisoning; Aconitum; pharmacology; phytochemistry; toxicology

Indexed keywords

ACONITINE; ACONITUM KARAKOLICUM EXTRACT; ALKALOID; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIPROTOZOAL AGENT; CYTOTOXIC AGENT; FATTY ACID; FLAVONOID; HERBACEOUS AGENT; HYPACONITINE; JESACONITINE; LAPPACONITINE; MESACONITINE; N DEACETYLLAPPACONITINE; NICOTINIC RECEPTOR; PLANT EXTRACT; POISON; POLYSACCHARIDE; UNCLASSIFIED DRUG; XUESHANGYIZHIHAO; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; PLANT MEDICINAL PRODUCT;

ABDOMINAL PAIN; ABRASION; ACONITE; ACONITUM CARMICHAELII; ACONITUM KARAKOLICUM; ANALGESIC ACTIVITY; ANTIARRHYTHMIC ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ANTIPROLIFERATIVE ACTIVITY; ANTIPROTOZOAL ACTIVITY; ARRHYTHMOGENESIS; ARTHRALGIA; CARDIOTOXICITY; COUGHING; DETOXIFICATION; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; ENDOCRINE DISEASE; FEVER; FLOWER; HEART ATRIUM FIBRILLATION; HEART VENTRICLE FIBRILLATION; HERBAL MEDICINE; HUMAN; INFLAMMATION; INTOXICATION; LEISHMANIA INFANTUM; MYALGIA; NEUROTOXICITY; NONHUMAN; PAW EDEMA; PHYTOCHEMISTRY; PLANT ROOT; REVIEW; RHEUMATIC FEVER; STRUCTURE ACTIVITY RELATION; TRADITIONAL MEDICINE; TRYPANOSOMA CRUZI; WOUND; CHEMISTRY; ORIENTAL MEDICINE; TOXICITY;

ACONITUM; ALKALOIDS; ANTI-INFECTIVE AGENTS; CARDIOVASCULAR AGENTS; CENTRAL NERVOUS SYSTEM AGENTS; DRUGS, CHINESE HERBAL; FATTY ACIDS, NONESTERIFIED; MEDICINE, EAST ASIAN TRADITIONAL; PHYTOCHEMICALS; PLANT ROOTS; POLYSACCHARIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84921472469     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12310     Document Type: Review

References (173)

1. Abbott A,. Survey questions safety of alternative medicine. Nature 2005; 436: 898.
2. Farnsworth NR, Morris RW,. Higher plants-the sleeping giant of drug development. Am J Pharm Sci Support Public Health 1976; 148: 46-52.
3. De Smet PA,. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 1997; 54: 801-840.
4. Cragg GM, et al. Natural products in drug discovery and development. J Nat Prod 1997; 60: 52-60.
5. Shu YZ,. Recent natural products based drug development: a pharmaceutical industry perspective. J Nat Prod 1998; 61: 1053-1071.
6. Akerele O,. Summary of WHO guidelines for the assessment of herbal medicines. HerbalGram 1993; 28: 13-19.
7. Maxwell G, et al. Pharmaceuticals from plants: great potential, few funds. Editorial. Lancet 1994; 343: 1513-1515.
8. Brevoort P,. The U.S. botanical market. An overview. HerbalGram 1995; 36: 49-59.
9. Blumenthal M,. Harvard study estimates consumers spend 5.1 billion on herbal products? HerbalGram 1999; 45: 68.
10. Blumenthal M,. Herb industry sees mergers, acquisitions, and entry by pharmaceutical giants in 1998. HerbalGram 1999; 45: 67-68.
11. Brevoort P,. Botanical (herbal) medicine in the United States. Pharm News 1996; 3: 26-28.
12. Eisenberg DM, et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993; 328: 246-252.
13. Fisher P, Ward A,. Complementary medicine in Europe. BMJ 1994; 309: 107-111.
14. Grunwald J,. The European phytomedicines market: figures, trends, analysis. HerbalGram 1995; 34: 60-65.
15. Roberts JE, Tyler VE,. Tyler's Herbs of Choice. The Therapeutic Use of Phytomedicinals. New York: The Haworth Press, Inc., 1998.
16. Blumenthal M, et al. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. Austin, TX: The American Botanical Council, 1998.
17. Normile D,. Asian medicine, the new face of traditional Chinese medicine. Science 2003; 299: 188-190.
18. Stone R,. Lifting the veil on traditional Chinese medicine. Science 2008; 319: 709-710.
19. Liang X, et al. Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats. J Proteome Res 2011; 10: 790-799.
20. World Health Organization. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicines, Vol. 1. Geneva: WHO, 2000: 1.
21. Xiao PG, et al. A pharmacophylogenetic study of Aconitum L. (Ranunculaceae) from China. Acta Phytotaxonomica Sin 2006; 44: 1-46.
22. Xie Y, et al. Simultaneous determination of six Aconitum alkaloids in proprietary Chinese medicines by high-performance liquid chromatography. J Chromatogr A 2005; 1093: 195-203.
23. Bisset NG,. Arrow poisons in China. Part II. Aconitum-botany, chemistry, and pharmacology. J Ethnopharmacol 1981; 4: 247-336.
24. Chan TYK,. Aconite poisoning. Clin Toxicol 2009; 47: 279-285.
25. World Health Organization. Medicinal Plants in China, Vol. 2, 2. Manila: WHO Regional Publications Western Pacific, 1989: 5.
26. Hou JP, Jin Y,. The Healing Power of Chinese Herbs and Medicinal Recipes. New York, London, Oxford: The Haworth Integrative Healing Press, 2005: 328-331.
27. Kimura M, et al. Hypaconitine, the dominant constituent responsible for the neuromuscular blocking action of the Japanese-sino medicine 'bushi' (aconite root). Jpn J Pharmacol 1988; 48: 290-293.
28. World Health Organization. Medicinal Plants in the Republic of Korea, Vol. 21. Manila: WHO Regional Publications Western Pacific, 1998: 5.
29. World Health Organization. Medicinal Plants in Vietnam, Vol. 3. Manila: WHO Regional Publications Western Pacific, 1990: 13.
30. Research, I.C.o.M. Medicinal Plants of India, Vol. 1. New Delhi: Indian Council of Medical Research, 1976: 15-18.
31. Kletter C, Kriechbaum M,. Tibetan Medicinal Plants. Stuttgart, Germany: Medpharm Scientific Publishers, 2001: 32-37.
32. Wang YY, Lu ZL,. Advanced Textbook of Internal Medicine of TCM (Zhongyi Neikexue Gaoji Jiaoxue Congshu). Beijing: People's Medical Publishing House, 1999: 912-963.
33. Tang W, Eisenbrand G,. Chinese Drugs of Plant Origin. Berlin-Heidelberg: Springer Verlag, 1992: 14-44.
34. Zhang CD,. Zhongyi Huoshengpai Tantao (Research on Divine-Fire Medical School in TCM). Beijing: People's Medical Publishing House, 2007: 57-112.
35. Halmai J, Novák I,. Medicina Könyvkiadõ. Farmakognõzia, 1963: 272-274.
36. Horhi MP,. Herbarium az faknac fuveknec nevekrbox drawings light down and leftl, természetekrbox drawings light down and leftl, és hasznairõl. Kolozsvár: Heltai Gáspárné Mhelye, 1578: 156.
37. Moog FP, Karenberg A,. Toxicology in the Old Testament. Did the High Priest Alcimus die of acute aconitine poisoning? Adverse Drug React Toxicol Rev 2002; 21: 151-156.
38. Pelletier SW,. Alkaloids: Chemical and Biological Perspectives. New York: Wiley, 1983.
39. Glasby J,. Encyclopedia of the Alkaloids, Vol. 1. New York, London: Plenum Press, 1975: 15-16.
40. Jacobs W, Elderfield R,. N-alkyl group of aconine (aconitine). J Am Chem Soc 1936; 58: 1059.
41. Wang Z, et al. Quantitative determination of diterpenoid alkaloids in four species of Aconitum by HPLC. J Pharm Biomed Anal 2006; 40: 1031-1034.
42. Pelletier SW, et al. The alkaloids of aconitum heterophyllum wall: isolation and characterization. Phytochemistry 1968; 7: 625-635.
43. Dzhakhangirov FN, Bessonova IA,. Alkaloids of Aconitum coreanum. X. Curare-like activity-structure relationship. Chem Nat Comp 2002; 38: 74-77.
44. Shim SH, et al. Alkaloidal constituents from Aconitum jaulense. Arch Pharm Res 2003; 9: 725-729.
45. Chodoeva A, et al. 8-O-Azeloyl-14-benzoylaconine: a new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activities. Bioorg Med Chem 2005; 13: 6493-6501.
46. Ahmad M, et al. Norditerpenoid alkaloids from the roots of Aconitum heterophyllum Wall with antibacterial activity. J Enzyme Inhib Med Chem 2008; 23: 1018-1022.
47. Nisar M, et al. New diterpenoid alkaloids from Aconitum heterophyllum Wall: selective butyrylcholinestrase inhibitors. J Enzyme Inhib Med Chem 2009; 24: 47-51.
48. Gao L-M, et al. Norditerpenoid alkaloids from Aconitum spicatum Stapf. J Integr Plant Biol 2006; 48: 364-369.
49. Bessonova IA, et al. Alkaloids of Aconitum coreanum. IV. 14-Hydroxy-2-isobutyrylhetisine N-oxide. Chem Nat Comp 1990; 26: 318-320.
50. Treutter D,. Significance of flavonoids in plant resistance and enhancement of their biosynthesis. Plant Biol (Stuttg) 2005; 7: 581-591.
51. Lim CE, et al. Flavonoid variation of the Aconitum jaluense complex (Ranunculaceae) in Korea. Plant Syst Evol 1999; 218: 125-131.
52. Fico G, et al. Flavonoids from Aconitum napellus subsp. neomontanum. Phytochemistry 2001; 57: 543-546.
53. Yue X-F, et al. Free fatty acids profile analysis of alcohol extract of Aconitum taipeicum Hand.-Mazz. with gas chromatography-mass spectrometry. Anal Methods 2010; 2: 668-672.
54. Zhao C, et al. Isolation and structural characterization of an immunostimulating polysaccharide from fuzi, Aconitum carmichaeli. Carbohydr Res 2006; 341: 485-491.
55. Gao T, et al. Antioxidant and immunological activities of water-soluble polysaccharides from Aconitum kusnezoffii Reichb. Int J Biol Macromol 2011; 49: 580-586.
56. Dzhakhangirov FN, et al. Diterpenoid alkaloids as a new class of antiarrhythmic agents. Structure-activity relationship. Chem Nat Comp 1997; 33: 190-202.
57. Ameri A,. The effects of Aconitum alkaloids on the central nervous system. Prog Neurobiol 1998; 56: 211-235.
58. Teuscher E, Lindequist U,. Biogene Gifte-Biologie, Chemie, Pharmakologie. Stuttgart, Jena, New York: Gustav Fischer, 1994: 517-523.
59. Wright SN,. Irreversible block of human heart (hH1) sodium channels by the plant alkaloid lappaconitine. Mol Pharmacol 2001; 59: 183-192.
60. Heubach JF, Schule A,. Cardiac effects of lappaconitine and N-deacetyllappaconitine, two diterpenoid alkaloids from plants of the Aconitum and Delphinium species. Planta Med 1998; 64: 22-26.
61. Chen WZ, et al. [Anti-arrhythmia effects of guan-fu base A]. [Article in Chinese]. Acta Pharmacol Sin 1983; 4: 247-250.
62. Mazur NA, et al. [Results of the clinical study of a new anti-arrhythmia preparation allapinin]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR 1986; 9: 30-33.
63. Polyakov NE, et al. Complexation of lappaconitine with glycyrrhizic acid: stability and reactivity studies. J Phys Chem B 2005; 109: 24526-24530.
64. Dzhakhangirov FN, Sadritinov FS,. Pharmacology of napelline and hetratisine alkaloids. Dokl Acad Nauk UzSSR 1977; 3: 50-51.
65. Friese J, et al. Aconitum sp. alkaloids: the modulation of voltage-dependent Na+ channels, toxicity and antinociceptive properties. Eur J Pharmacol 1997; 337: 165-174.
66. Murayama M, et al. Mechanism of analgesic action of mesaconitine. I. Relationship between analgesic effect and central monoamines or opiate receptors. Eur J Pharmacol 1984; 101: 29-36.
67. Liou SS, et al. Comparison of the antinociceptive action of crude Fuzei, the root of Aconitum, and its processed products. J Ethnopharmacol 2005; 99: 379-383.
68. Seitz U, Ameri A,. Different effects on [3H]noradrenaline uptake of the Aconitum alkaloids aconitine, 3-acetylaconitine, lappaconitine, and N-desacetyllappaconitine in rat hippocampus. Biochem Pharmacol 1998; 55: 883-888.
69. Hikino H, et al. Mechanism of inhibitory action of mesaconitine in acute inflammations. Eur J Pharmacol 1982; 82: 65-71.
70. Ameri A,. Effects of the alkaloids 6-benzoylheteratisine and heteratisine on neuronal activity in rat hippocampal slices. Neuropharmacology 1997; 36: 1039-1046.
71. Ameri A,. Inhibition of rat hippocampal excitability by the Aconitum alkaloid, 1-benzoylnapelline, but not by napelline. Eur J Pharmacol 1997; 335: 145-152.
72. Ameri A,. Structure-dependent differences in the effects of the Aconitum alkaloids lappaconitine, N-desacetyllappaconitine and lappaconidine in rat hippocampal slices. Brain Res 1997; 769: 36-43.
73. Ameri A,. Structure-dependent inhibitory action of the Aconitum alkaloids 14-benzoyltalitasamine and talitasamine in rat hippocampal slices. Naunyn Schmiedebergs Arch Pharmacol 1998; 357: 585-592.
74. Ameri A, et al. Inhibition of neuronal activity in rat hippocampal slices by Aconitum alkaloids. Brain Res 1996; 738: 154-157.
75. Ameri A,. Inhibition of rat hippocampal excitability by the plant alkaloid 3-acetylaconitine mediated by interaction with voltage-dependent sodium channels. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 273-280.
76. Ameri A, Simmet T,. Interaction of the structurally related aconitum alkaloids, aconitine and 6-benzyolheteratisine, in the rat hippocampus. Eur J Pharmacol 1999; 386: 187-194.
77. Ameri A,. Inhibition of stimulus-triggered and spontaneous epileptiform activity in rat hippocampal slices by the Aconitum alkaloid mesaconitine. Eur J Pharmacol 1998; 342: 183-191.
78. Ameri A,. Effects of the Aconitum alkaloid songorine on synaptic transmission and paired-pulse facilitation of CA1 pyramidal cells in rat hippocampal slices. Br J Pharmacol 1998; 125: 461-468.
79. Zhao XY, et al. Songorine, a diterpenoid alkaloid of the genus Aconitum, is a novel GABA(A) receptor antagonist in rat brain. Neurosci Lett 2003; 337: 33-36.
80. Ward JM, et al. Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites. FEBS Lett 1990; 270: 45-48.
81. Alkondon M, et al. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol Pharmacol 1992; 41: 802-808.
82. Hardick DJ, et al. Conversion of the sodium channel activator aconitine into a potent α7-selective nicotinic ligand. FEBS Lett 1995; 365: 79-82.
83. Hardick DJ, et al. Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal alpha-bungarotoxin binding sites: importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding. J Med Chem 1996; 39: 4860-4866.
84. Navarro HA, et al. Synthesis and pharmacological characterization of ((125)I)iodomethyllycaconitine (((125)I)iodo-MLA). A new ligand for the alpha(7) nicotinic acetylcholine receptor. J Med Chem 2000; 43: 142-145.
85. Tucci SA, et al. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology 2003; 44: 367-373.
86. Chilton M, et al. Behavioral consequences of methyllycaconitine in mice: a model of alpha7 nicotinic acetylcholine receptor deficiency. Life Sci 2004; 74: 3133-3139.
87. Leonard S, et al. Smoking and schizophrenia: abnormal nicotinic receptor expression. Eur J Pharmacol 2000; 393: 237-242.
88. Martin SE, et al. The alpha7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against beta-amyloid1-42 toxicity in primary neuron-enriched cultures. Brain Res 2004; 1022: 254-256.
89. Gonzalez P, et al. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum. Int J Antimicrob Agents 2005; 25: 136-141.
90. Gonzalez P, et al. Diterpenoid alkaloid derivatives as potential chemotherapeutic agents in American trypanosomiasis. Pharmacology 2006; 76: 123-128.
91. Gonzalez-Coloma A, et al. Structural diversity and defensive properties of norditerpenoid alkaloids. J Chem Ecol 2004; 30: 1393-1408.
92. Gonzalez-Coloma A, et al. Antifeedant C20 diterpene alkaloids. Chem Biodivers 2004; 1: 1327-1335.
93. de Ines C, et al. In vitro cytotoxicity of norditerpenoid alkaloids. Z Naturforsch [C] 2006; 61: 11-18.
94. Bello-Ramirez AM, et al. A QSAR analysis to explain the analgesic properties of Aconitum alkaloids. Fundam Clin Pharmacol 2003; 17: 575-580.
95. Gutser UT, et al. Mode of antinociceptive and toxic action of alkaloids of Aconitum spec. Naunyn Schmiedebergs Arch Pharmacol 1997; 357: 39-48.
96. Wang XW, Xie H,. Alkaloids of Chinese Aconitum plants. Drugs Future 1999; 24: 877-882.
97. Nakayama A, et al. QSAR of fungicidal D3-1,2,4-thiadiazolines: reactivity-activity correlation of S-H inhibitors. Quant Struct Act Relat 1993; 12: 251-255.
98. Katz A, Rudin H,. Milde alkalische Hydrolyse von Aconitin. Helv Chim Acta 1984; 67: 2017-2022.
99. Zhou YP, et al. Toxicity of aconitine and its analogs and their effects on cardiac contractive function. Acta Pharmacol Sin 1984; 19: 641-646.
100. Yang QH,. Poisoning of Aconitum species and its prevention and treatment. Chin J Integr Tradit West Med 1985; 5: 511-512.
101. Mitsuo M, et al. Studies on the constituents of Aconitum species. IX. The pharmacological properties of pyro-type aconitine alkaloids, components of processed aconite powder 'Kako-bushi-matsu': analgesic, antiinflammatory and acute toxic activities. J Ethnopharmacol 1991; 35: 159-164.
102. Isono T, et al. The analgesic mechanism of processed Aconiti tuber: the involvement of descending inhibitory system. Am J Chin Med 1994; 22: 83-94.
103. Ono M, Satoh T,. Pharmacological studies of lappaconitine. Analgesia produced by intacerebroventricular, intracisternal and intrathecal injections. J Pharmacobiodyn 1990; 13: 374-377.
104. Dzhakhangirov FN, Sadritinov FS,. Antiarrhythmic effect of allapanine (lappaconitine hydrobromide). Dokl Acad Nauk UzSSR 1985a; 3: 46-47.
105. Dzhakhangirov FN, Sadritinov FS,. Comparison of the antiarrhythmic and antifibrallatory activities of allapanine and other antiarrhythmic drugs. Dokl Acad Nauk UzSSR 1985b; 7: 47-48.
106. Sokolov SF, et al. [Effect of allapinin on the function of the atrioventricular conduction system of the heart]. Kardiologiia 1988; 28: 90-95.
107. Abdalla A, et al. Pharmacokinetics and pharmacodynamics of a new antiarrhythmic drug, allapanin, used as pills. Kardiologiya 1989; 29: 32-36.
108. Ameri A,. Age-dependent differences in sensitivity to aconitine of rat hippocampal slices. Neurosci Lett 1996; 216: 13-16.
109. Deffois A, et al. Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci Lett 1996; 220: 117-120.
110. Dray A, et al. Pharmacology of chronic pain. Trends Pharmacol Sci 1994; 15: 190-197.
111. Benn MH, Jacyno JM,. The toxicology and pharmacology of diterpenoid alkaloids. In:, Pelletier SW, ed. Alkaloids: Chemical and Biological Perspectives. New York: Wiley, 1983: 153-210.
112. Ameri A,. Electrophysiological actions of the plant alkaloid 6-benzoylheteratisine in rat hippocampal slices. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 538-544.
113. Ding LS, et al. Diterpenoid alkaloids from Aconitum gymnandrum. Yao Xue Xue Bao 1993; 28: 188-191.
114. Lin CC, et al. Clinical features and management of herb-induced aconitine poisoning. Ann Emerg Med 2004; 43: 574-579.
115. Moritz F, et al. Severe acute poisoning with homemade Aconitum napellus capsules: toxicokinetic and clinical data. Clin Toxicol (Phila) 2005; 43: 873-876.
116. Lowe L, et al. Herbal aconite tea and refractory ventricular tachycardia. N Engl J Med 2005; 353: 1532.
117. Chan TY,. Aconitine poisoning: a global perspective. Vet Hum Toxicol 1994; 36: 326-328.
118. Zhao S, et al. Analysis of the aconitine alkaloids in traditional Chinese medicines by nonaqueous capillary electrophoresis using a new recording mode. Biomed Chromatogr 2004; 18: 381-387.
119. Ralphs MH, et al. Toxicophenology and grazing risk models of tall larkspur. cabdirect, 2001: 573-581.
120. Lee ST, et al. Evaluation of vaccination against methyllycaconitine toxicity in mice. J Anim Sci 2003; 81: 232-238.
121. Ohta H, et al. Determination of Aconitum alkaloids in blood and urine samples. I. High-performance liquid chromatographic separation, solid-phase extraction and mass spectrometric confirmation. J Chromatogr B Biomed Sci Appl 1997; 691: 351-356.
122. Commission C,. Pharmacopoeia of the People's Republic of China. Beijing: People's Medical Publishing House, 2005.
123. Fu M, et al. Toxicological mechanisms of Aconitum alkaloids. Pharmazie 2006; 61: 735-741.
124. Manners GD, et al. Structure-activity relationships of norditerpenoid alkaloids occurring in toxic larkspur (Delphinium) species. J Nat Prod 1995; 58: 863-869.
125. Liu F, et al. [Determination of three kind of diester diterpenoid alkaloids (DDAs) in Aconitum carmichaeli and its processed products by HPLC]. Zhongguo Zhong Yao Za Zhi 2006; 31: 1160-1162.
126. Yang L, et al. Comparative studies on acute toxicity and pharmacodynamics of Aconitum carmichaeli. J Beijing Univ Tradit Chin Med 1997; 2: 20-21.
127. Kitagawa I, et al. Chemical studies on crude drug processing. III. Aconiti tuber (2). On the constituents of Pao-fuzi, the processed tuber of Aconitum carmichaeli Debeaux and biological activities of lipo-alkaloids. Yakugaku Zasshi 1984; 104: 858-866.
128. Chen JH, et al. Determination of aconitine-type alkaloids as markers in fuzi (Aconitum carmichaeli) by LC/(+)ESI/MS(3). J Pharm Biomed Anal 2008; 48: 1105-1111.
129. Jiang ZH, et al. Quantification of Aconitum alkaloids in aconite roots by a modified RP-HPLC method. Phytochem Anal 2005; 16: 415-421.
130. Xie Y, et al. An optimized high-performance liquid chromatography (HPLC) method for benzoylmesaconine determination in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) and its products. Chin Med 2008; 3: 6.
131. Csupor D, et al. Bisnorditerpene, norditerpene, and lipo-alkaloids from Aconitum toxicum. J Nat Prod 2008; 71: 1779-1782.
132. Csupor D, et al. Qualitative and quantitative analysis of aconitine-type and lipo-alkaloids of Aconitum carmichaelii roots. J Chromatogr A 2009; 1216: 2079-2086.
133. Hikino H, et al. Analgesic principles of Aconitum roots. J Pharmacobiodyn 1979; 2: 78-83.
134. Suzuki Y, et al. [Analgesic effect of benzoylmesaconine]. Nihon Yakurigaku Zasshi 1993; 102: 399-404.
135. de Rijke E, et al. Liquid chromatography coupled to nuclear magnetic resonance spectroscopy for the identification of isoflavone glucoside malonates in T. pratense L. leaves. J Sep Sci 2004; 27: 1061-1070.
136. Yue H, et al. Studies on the aconitine-type alkaloids in the roots of Aconitum carmichaeli Debx. by HPLC/ESIMS/MS(n). Talanta 2009; 77: 1800-1807.
137. Wang X, et al. Metabolomics study on the toxicity of aconite root and its processed products using ultraperformance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition approach and ingenuity pathways analysis. J Proteome Res 2012; 11: 1284-1301.
138. Manna SK, et al. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J Proteome Res 2011; 10: 4120-4133.
139. Castro-Perez JM, et al. Identifying static and kinetic lipid phenotypes by high resolution UPLC-MS: unraveling diet-induced changes in lipid homeostasis by coupling metabolomics and fluxomics. J Proteome Res 2011; 10: 4281-4290.
140. Li L, et al. Metabonomic study on the toxicity of Hei-Shun-Pian, the processed lateral root of Aconitum carmichaelii Debx. (Ranunculaceae). J Ethnopharmacol 2008; 116: 561-568.
141. van Beek TA, et al. Quantitation of bilobalide and ginkgolides A, B, C and J by means of nuclear magnetic resonance spectroscopy. Phytochem Anal 1993; 4: 261-268.
142. Cogne AL, et al. On-line identification of unstable catalpol derivatives from Jamesbrittenia fodina by LC-mS and LC-NMR. Phytochem Anal 2003; 14: 67-73.
143. Seger C, et al. LC-DAD-MS/SPE-NMR hyphenation. A tool for the analysis of pharmaceutically used plant extracts: identification of isobaric iridoid glycoside regioisomers from Harpagophytum procumbens. Anal Chem 2005; 77: 878-885.
144. Cogne AL, et al. On-line identification of unstable iridoids from Jamesbrittenia fodina by HPLC-MS and HPLC-NMR. Phytochem Anal 2005; 16: 429-439.
145. Holzgrabe U, et al. NMR spectroscopy in pharmacy. J Pharm Biomed Anal 1998; 17: 557-616.
146. Zhu ZY, et al. Determination of mesaconitine, hypaconitine and aconitine in Xiaohuoluo pills by TLC-HPLC. Chin J Pharm Anal 1996; 16: 154-157.
147. Li SP, et al. Determination of nucleosides in natural Cordyceps sinensis and cultured Cordyceps mycelia by capillary electrophoresis. Electrophoresis 2001; 22: 144-150.
148. Ye N, et al. Determination of scopolamine, atropine and anisodamine in Flos daturae by capillary electrophoresis. Biomed Chromatogr 2001; 15: 509-512.
149. Cheung HY, et al. Rapid and simultaneous analysis of some bioactive components in Eucommia ulmoides by capillary electrophoresis. J Chromatogr A 2003; 989: 303-310.
150. Sun SW, Tseng HM,. Improved detection of Coptidis alkaloids by field-amplified sample stacking in capillary electrophoresis. J Pharm Biomed Anal 2004; 36: 43-48.
151. Sun SW, Tseng HM,. Sensitivity improvement on detection of Coptidis alkaloids by sweeping in capillary electrophoresis. J Pharm Biomed Anal 2005; 37: 39-45.
152. Liu L, et al. Separation and determination of tetrandrine and fangchinoline in herbal medicines by flow injection-micellar electrokinetic capillary chromatography with internal standard method. J Chromatogr A 2005; 1098: 177-182.
153. Qi S, et al. Novel and simple nonaqueous capillary electrophoresis separation and determination bioactive triterpenes in Chinese herbs. J Pharm Biomed Anal 2006; 40: 35-41.
154. Liu JJ, et al. Optimization for quantitative determination of four flavonoids in Epimedium by capillary zone electrophoresis coupled with diode array detection using central composite design. J Chromatogr A 2006; 1103: 344-349.
155. Ito K, et al. Distribution of Aconitum alkaloids in body fluids and tissues in a suicidal case of aconite ingestion. J Anal Toxicol 2000; 24: 348-353.
156. Ito K, et al. Report on the preparation of deuterium-labelled aconitine and mesaconitine and their application to the analysis of these alkaloids from body fluids as internal standard. J Chromatogr B Biomed Sci Appl 1998; 714: 197-203.
157. Ito K, et al. Determination of Aconitum alkaloids in the tubers of Aconitum japonicum using gas chromatography/selected ion monitoring. Planta Med 1996; 62: 57-59.
158. Ito K, et al. Method for the simultaneous determination of Aconitum alkaloids and their hydrolysis products by gas chromatography-mass spectrometry in human serum. Planta Med 1997; 63: 75-79.
159. Yoshioka N, et al. A case of aconitine poisoning with analysis of aconitine alkaloids by GC/SIM. Forensic Sci Int 1996; 81: 117-123.
160. Hayashida M, et al. A column-switching LC/MS/ESI method for detecting tetrodotoxin and Aconitum alkaloids in serum. Leg Med (Tokyo) 2003; 5 (Suppl. 1): S101-S104.
161. Van Landeghem AA, et al. Aconitine involvement in an unusual homicide case. Int J Legal Med 2007; 121: 214-219.
162. Miyaguchi H, Sekine H,. Homicide involving Aconitum tuberous root: LC-MS-MS analysis of Aconitum alkaloids and their hydrolysates in formalin-fixed tissues. Forensic Toxicol 2010; 28: 47-51.
163. Strzelecki A, et al. Acute toxic herbal intake in a suicide attempt and fatal refractory ventricular arrhythmia. Basic Clin Pharmacol Toxicol 2010; 107: 698-699.
164. Pullela R, et al. A case of fatal aconitine poisoning by Monkshood ingestion. J Forensic Sci 2008; 53: 491-494.
165. Zhang F, et al. Simultaneous quantitation of aconitine, mesaconitine, hypaconitine, benzoylaconine, benzoylmesaconine and benzoylhypaconine in human plasma by liquid chromatography-tandem mass spectrometry and pharmacokinetics evaluation of 'SHEN-FU' injectable powder. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 873: 173-179.
166. Zhang HG, et al. Separation and identification of Aconitum alkaloids and their metabolites in human urine. Toxicon 2005; 46: 500-506.
167. Mizugaki M, et al. Analysis of Aconitum alkaloids by gas ion monitoring. Eisei Kagaku 1988; 34: 359-365.
168. Guo FQ, et al. Determination of the volatile chemical constituents of Notoptergium incium by gas chromatography-mass spectrometry and iterative or non-iterative chemometrics resolution methods. J Chromatogr A 2003; 1016: 99-110.
169. Guo FQ, et al. Analyzing of the volatile chemical constituents in Artemisia capillaris herba by GC-MS and correlative chemometric resolution methods. J Pharm Biomed Anal 2004; 35: 469-478.
170. Gong F, et al. Determination of volatile components in peptic powder by gas chromatography-mass spectrom etry and chemometric resolution. J Chromatogr A 2001; 909: 237-247.
171. Gong F, et al. Gas chromatography-mass spectrometry and chemometric resolution applied to the determination of essential oils in Cortex cinnamomi. J Chromatogr A 2001; 905: 193-205.
172. Deng C, et al. Fast determination of curcumol, curdione and germacrone in three species of Curcuma rhizomes by microwave-assisted extraction followed by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J Chromatogr A 2006; 1117: 115-120.
173. Deng C, et al. Development of microwave-assisted extraction followed by headspace solid-phase microextraction and gas chromatography-mass spectrometry for quantification of camphor and borneol in Flos Chrysanthemi Indici. Anal Chim Acta 2006; 575: 120-125.